According to recent market analysis, the global PARP inhibitor market, valued at USD 6,279.90 million in 2024, is set to witness exceptional growth, reaching USD 16,153.50 million by 2034. This ...

Trump’s tariff threats and Kennedy’s anti-vaccine stance makes US a hostile environment for pharma companies ...

Gabii sa Kabilin (GSK) blooms into its 18th year this 2025, a relevant and timely theme is set to drive a vibrant and ...

CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a ...

GSK PLC GSK shares advanced 2.13% to £14.84 Tuesday, on what proved to be an all-around positive trading session for the ...

Bank stocks led European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.80% to 1,418.65 on the S&P Europe Select ADR Index. From continental Europe, ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab --PASADENA, ...

Unilever Chairman Ian Meakins thanked Schumacher, who is being treated as a “good leaver” for the purposes of his outstanding incentives. The outgoing CEO will continue to receive his fixed pay of ...

For the first time, the U.S. Department of Agriculture has confirmed the presence of H5N1 avian influenza in rats, raising ...

London, UK Tuesday, February 25, 2025, 15:00 Hrs [IST] GSK plc (GSK) announces the commencement of its share buyback programme (the “Progr ...